The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection of actionable BRAF missense mutations by ctDNA-based genomic analysis in prostate cancer.
 
Malshundria Prophet
No Relationships to Disclose
 
Kun Xiao
No Relationships to Disclose
 
Theodore Stewart Gourdin
Research Funding - Ferring (Inst)
 
Rebecca J Nagy
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Lesli Ann Kiedrowski
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - McKinsey & Company
 
Elisa Ledet
No Relationships to Disclose
 
Guru Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Agensys; Amgen; Argos Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Janssen; Merck; Novartis; Pfizer; Sanofi
Speakers' Bureau - Clinical Care Options/NCCN; Onclive; Physicans' Education Resource
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Onyx (Inst); Pfizer (Inst)
Other Relationship - AstraZeneca; Boehringer Ingelheim
 
A. Oliver Sartor
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bellicum Pharmaceuticals; Dendreon; Endocyte; Johnson & Johnson; Medivation; Oncogenex; Progenics (Inst); Sanofi; Tokai Pharmaceuticals
Research Funding - Bayer (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); InVitae (Inst); Johnson & Johnson (Inst); Progenics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bellicum Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Progenics; Sanofi; Tokai Pharmaceuticals
 
Michael B. Lilly
Research Funding - Bavarian Nordic